Clinical trials
catalyst calendar across sponsors →Studies where ESTA is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
4 interventional · 3 observational
Held by 12 tracked-famous managers (D. E. Shaw & Co., Inc., TWO SIGMA INVESTMENTS, LP, JANE STREET GROUP, LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, +7 more) · FINRA short interest 9.9 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 4 sells · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| Clinical Study on Tissue Preservation in Breast Augmentation and ReconstructionNCT07623564observationalNumber of Adverse Events Related to Tissue Preservation | — | Enrolling by invitation | Procedure: Mia Harmonization, Mia Scarless Lift, Mia Reconstruction, Joy Dot, Maxtopexia + Mia | Breast Augmentation and Breast Reconstruction, Mammaplasty, Breast Augmentation, Tissue Preservation | 60 | 2026-12-31 | in 134 d | 2026-06-03 |
| Motiva Flora® Aesthetic Breast Recon® Clinical StudyNCT06146231Total adverse envent rateOpen-label · Other | Not applicable | Recruiting | Device: Motiva Flora® Tissue Expander | Mammaplasty, Breast Cancer, Poland Syndrome | 66 | Apr 2026 | — | 2025-11-26 |
| Adaptive Study to Assess the Safety and Functioning of Motiva Devices on Minimally Invasive Gluteal AugmentationNCT07135011Primary Safety e:valuationOpen-label · Other | Not applicable | Recruiting | Device: Primary gluteal enhancement | Device Safety | 120 | Apr 2026 | — | 2025-08-21 |
| Motiva Flora Tissue Expander PMCFNCT05447988Incidence of the device and procedure-related adverse eventsOpen-label · Treatment | Not applicable | Recruiting | Device: Breast Tissue Expander | Breast Tissue Accessory, Breast Cancer | 136 | 2024-12-15 | — | 2024-08-27 |
| Mia® Clinical StudyNCT06792409SafetyOpen-label · Other | Not applicable | Completed | Device: Minimally invasive breast augmentation procedure with a trans-axillary approach. | Breast Augmentation | 100 | 2024-08-08actual | — | 2025-01-24 |
| Retrospective Data Collection on the Use of Motiva Flora TE in Breast ReconstructionNCT05459064observationalSafety - adverse events | — | Completed | Device: Motiva Flora TE | Breast Cancer | 144 | 2024-06-30actual | — | 2024-08-27 |
| Safety and Performance of Motiva® SizersNCT06274736observationalMotiva Sizers Safety (complications) | — | Completed | Device: Motiva Sizer | Breast Implant; Complications, Breast Implantation; Methods, Safety and Performance, Mammaplasty, Breast Reconstruction, Breast Augmentation | 133 | 2023-12-10actual | — | 2026-06-02 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19